A recent study published in JAMA Neurology explains new techniques that may help expedite research by allowing scientists to assess results of experimental treatments using PET (Positron Emission Tomography) imaging technology. Until now, synaptic loss could be measured only in autopsy. Kind of tough to assess if a newly developed drug is working after someone’s dead.
The article is science-heavy, but the video provides a good overview. The results arose from a collaboration between the Yale PET Center and the Yale Alzheimer’s Disease Research Unit.